Lundbeck launches new antidepressant

depression concept: rain clouds
Lundbeck Australia has announced the launch of a new antidepressant, for the treatment of major depressive disorder in adults including the prevention of relapse. This is the first new antidepressant to be introduced in Australia for almost five years. Brintellix (vortioxetine) has a novel mechanism of action and is known as mult-modal as it is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Charnwood Capital Chemist donates breast pump to hospital
Next Pharmacists fighting antimicrobial resistance